Aggrenox, a new aspirin and dipyridamole combination

January 2000

Boehringer Ingelheim is now introducing Aggrenox, a new aspirin and dipyridamole combination...to prevent stroke in patients who have already had an ischemic stroke or TIA.

Dipyridamole fell out of favor years ago because there wasn't enough evidence to show that it was effective.

But now there's convincing evidence that Aggrenox is MORE effective than aspirin alone to prevent recurrent stroke.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote